Omair has been an entrepreneur in Biotechnology, Neurotechnology and Finance, following a 12-year career in Trading and Portfolio Management. He launched a systematic trading firm, premised on his research in chaos theory and patterns.

His transition into Biotech, inspired by medical challenges, was in building and scaling ventures to target pain management with non-opioids and pathogens including SARS-CoV-2 with nanobodies and small molecules. His work was nominated at World Economic Forum COVID-19 Response Challenge in 2020, following his research in Pandemics in 2007. Currently, his venture Lagrangian is scaling Kondor Pharma a Canadian Biotech building nutraceutical and RX products to target inflammation.

He launched Neurometry, where the team is unifying Biomedical Engineering and Neurology to design tools for a Telemedicine Platform with Gamification to diagnose and manage patients with neurological and neuro cognitive disorders.